Purdue Pharma and its owners have agreed to a $270 million settlement with Oklahoma in the state’s lawsuit claiming OxyContin contributed to an opioid epidemic, according to multiple publications. The settlement was to be announced at a press conference on Tuesday, report Reuters, the Washington Post, Bloomberg and the Wall…
Mar 26, 2019 12:43 PM CDT